Drug Profile
KI 04208
Alternative Names: KI 04 208Latest Information Update: 23 Aug 2006
Price :
$50
*
At a glance
- Originator Kos Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haematological disorders
Most Recent Events
- 23 Aug 2006 Discontinued - Preclinical for Haematological disorders in USA (Inhalation)
- 18 Jun 2003 Preclinical trials in Haematological disorders in USA (Inhalation)